Wide and plenty of investment and business experiences covers from start-up to IPO
Broad and strong network in the Industry, Academia and the Research Institutes worldwide.
MBL business field does not narrow our investment target area.
Utilize our considerable experience and expertise in lifescience industry.
business resources in Japan and other countries, utilizing MBL Group and other network including JSR
January 12, 2000
2nd Floor Ogawa Bldg., 1-2-2 Uchikanda, Chiyoda-ku, Tokyo 101-0047 JAPAN
President / Yasuyo KAYAMA
Senior Manager / Masako HASHIMOTO
Manager / Masaya ISHIBASI
Board Member / Takashi MORITSU
Board Member /Kimimasa YAMADA
Ms. Masako Hashimoto joined mblVC in March 2014. Prior to joining mblVC, she served as General Manager at Yasuda Enterprise Development Co., Ltd., Japan's major VC firm with $800M under management, from 2007 to 2014. She headed Yasuda’s Life Science investment team both in the US and in Japan and her team invested more than $50M. Prior to Yasuda, she was a venture capitalist since 1990 to 1999, with Nippon Enterprise Development Co., Ltd., one of the oldest venture capital firm in Japan. She graduated Tokyo University of Foreign Studies.
We invest in the emerging companies in the following areas:
Diagnostic Devices (ex. Microfluidics, POCT)
Drug Delivery System
Start-up ～ pre-IPO
US$1M ～ US$2M for initial investment
US$2M ～ US$3M per company
Principally in North America and in Japan
Secondarily in European countries
Prefer to be a part of an investment syndicate with leading VC firms
Preferable but not a necessary condition